Patents-Review.com
🔗 Permalink
Assignee profile:

Roche GlycArt AG

City:

Country:

Switzerland

Published Applications:

11

Last publication date:

2022-09-08

Patent Grants:

11

Last grant date:

2025-04-29

Top Inventors for applications by Roche GlycArt AG

These are the the leading inventors for applications assigned to Roche GlycArt AG:

Recent patent applications by Roche GlycArt AG

Roche GlycArt AG based in , CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2022-09-08 ✅ Patent 12,286,486 granted on 2025-04-29
US20220281995A1
Chemistry; metallurgy

Anti-FAP antibodies and methods of use

 #2 | 2017-04-20 ✅ Patent 10,352,943 granted on 2019-07-16
US20170108510A1
Physics

A-fucosylation detection in antibodies

 #3 | 2016-11-24 ✅ Patent 10,040,843 granted on 2018-08-07
US20160340413A1
Chemistry; metallurgy

Interleukin-10 fusion proteins and uses thereof

 #4 | 2016-07-21 ✅ Patent 10,323,098 granted on 2019-06-18
US20160208017A1
Chemistry; metallurgy

Mutant interleukin-2 polypeptides

 #5 | 2014-01-16 ✅ Patent 9,695,233 granted on 2017-07-04
US20140017244A1
Chemistry; metallurgy

Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases

 #6 | 2013-02-05 ✅ Patent 8,367,374 granted on 2013-02-05
US10761435
-

Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function

 #7 | 2012-05-17 ✅ Patent 8,623,644 granted on 2014-01-07
US20120122206A1
Chemistry; metallurgy

Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity

 #8 | 2011-12-01 ✅ Patent 10,106,600 granted on 2018-10-23
US20110293613A1
Chemistry; metallurgy

Bispecific antibodies

 #9 | 2011-06-16 ✅ Patent 8,629,248 granted on 2014-01-14
US20110142825A1
Chemistry; metallurgy

Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity

 #10 | 2011-05-05 ✅ Patent 9,068,008 granted on 2015-06-30
US20110104148A1
Chemistry; metallurgy

Antibodies to carcinoembryonic antigen (CEA), methods of making same, and uses thereof

 #11 | 2009-12-10 ✅ Patent 9,068,005 granted on 2015-06-30
US20090304690A1
Chemistry; metallurgy

Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
AssigneeID:

474082 ⎘